JeffreyJ.TarrandMD

Pathology • Houston, TX

Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Tarrand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tarrand's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1987 - 1988
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1986
University of Virginia Medical CenterResidency, Pathology-Anatomic and Clinical, 1981 - 1983
University of Virginia School of MedicineClass of 1980

Certifications & Licensure

TX State Medical License 1988 - 2025
American Board of Pathology Clinical Pathology

Publications & Presentations

PubMed

Determinant of 30-Day Mortality of Pulmonary Legionellosis: Do Coinfections Matter?
Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Jeffrey Tarrand, Scott E Evans
Open Forum Infectious Diseases. 2024-09-01
7 citations
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes.
Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Koji Sasaki, Jeffrey Tarrand
The Journal of Antimicrobial Chemotherapy. 2024-02-01
Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordance Between Responses of Skin Lesions and Systemic Outcomes.
Takahiro Matsuo, Sebastian Wurster, Ying Jiang, Jeffrey Tarrand, Dimitrios P Kontoyiannis
Open Forum Infectious Diseases. 2024-02-01